CPT Capital

CPT Capital is defined by the companies we invest in. We support the brightest companies driving the animal-free technology revolution. From optogenetic manufacturing to molecular farming to cell-based meat, we back the most promising solutions from pre-Seed and Seed all the way through to sale, IPO and beyond.

Our investment criteria is based on backing teams and ideas aiming to revolutionise global animal supply chains at the earliest possible opportunity. Specifically, CPT Capital is looking for companies that are seeking to directly replace an animal-derived product and have strong technical barriers to entry or an IP-protected element.

We make investment decisions based on the potential for transforming animal dependent production systems, as well as the potential to achieve extraordinary capital growth.

We look to invest as early as pre-Seed and Seed stages and are open to opportunities across the globe. We are looking for passionate and dynamic founders with a strong vision and mission alignment to drive the future of an animal-free supply chain.